New heart stent aims to cut blood thinner time, lower bleeding risk
Disease control
Recruiting now
This study is tracking 2,000 heart disease patients who receive the VIVO ISAR stent, a drug-coated device that releases medication to keep arteries open. Participants will take blood thinners for three months or less after the procedure. Researchers are monitoring for heart attac…
Sponsor: Translumina Therapeutics Pvt Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:10 UTC